webinar register page

Webinar banner
Clinical Cases to Enhance Knowledge – For Patients with Chronic Lymphocytic Leukemia

Dr. Chai Phua-Assistant Professor of Medicine, Western University and Medical Co-Director of Coagulation Laboratory, Victoria Hospital
Dr. Sue Robinson-Hematologist, QEII Health Sciences Centre. Professor, Dalhousie University
Dr. Nicole Laferriere-Hematologist, Regional Cancer Program. Systemic Therapy Regional Quality Lead, Cancer Care Ontario. Medical Director & Chief of Oncology, Regional Cancer Care Northwest. Associate Professor, Northern Ontario School of Medicine

At the end of the session participants will be able to:
1. Discuss the indications for initiation of therapy for patients with chronic lymphocytic leukemia.
2. Describe the front-line treatment options for chronic lymphocytic leukemia using a case-based approach.
3. Apply the principles of risk-adapted treatment using case-based scenarios to illustrate the impact of patient attributes and disease specific attributes in the management of chronic lymphocytic leukemia.
4. Discuss the various available front-line treatment options within the Canadian landscape.

Target Audience: Hematologists

Medical Expert (the integrating role)
Health Advocate

Declaration of Conflict of Interest:
Dr. Phua - AstraZeneca, NovoNordisk, Pfizer, Janssen, Takeda, Gilead, Bayer, BMS, Sanofi, Octapharma, Amgen, Roche
Dr. Laferriere - AbbVie, AstraZeneca, Beigene, Celgene/BMS, Incyte, KITE, Novartis, Roche, Jansson, Leo Pharma, Pfizer, Baxter
Dr. Robinson - Abbvie, Acerta, Beigene, Celgene, Janssen

This activity is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada and approved by the Canadian Association of Pathologists (CAP-AC). You may claim a maximum of 1.0 hours.

This webinar was co-developed with Astra Zeneca and the CHS and was planned to achieve scientific integrity, objectivity and balance.

Jun 3, 2022 12:00 PM in Eastern Time (US and Canada)

Webinar logo
* Required information


Dr. Chai Phua
Assistant Professor of Medicine and Adult Clinical Hematologist @Department of Medicine, Western University
Chai Phua is an Assistant Professor of Medicine in the Department of Medicine at Western University and is an adult clinical hematologist focusing on lymphoproliferative disorders, multiple myeloma and bleeding disorders. He is also the Medical Co-Director of the Coagulation Laboratory at Victoria Hospital. He began his medical school training in Malaysia and subsequently completed his medical training and Internal Medicine subspecialty at Memorial University. He then completed additional postgraduate training in Hematology at the University of Toronto. He has been a staff hematologist in London since 2017.
Dr. Nicole Laferriere
Medical Director & Chief of Oncology @Regional Cancer Care Northwest
Dr. Laferriere completed an HBSc degree in Medical Laboratory Science at Lakehead University and a PhD in Cell Biology at the University of Ottawa. She completed her undergraduate medical degree at McMaster University, and then attended the University of Ottawa for an Internal Medicine Residency and Hematology Fellowship. Dr. Laferriere has been a full time Hematologist in the Regional Cancer Program since 2005. In 2012 she was appointed as the Systemic Therapy Regional Quality Lead for Cancer Care Ontario and currently holds the position of Medical Director & Chief of Oncology for Regional Cancer Care Northwest. Dr. Laferriere holds an academic appointment as Associate Professor in Internal Medicine at the Northern Ontario School of Medicine.
Dr. Sue Robinson
Hematologist and Professor @QEII Health Sciences Centre and Dalhousie University
Dr. Robinson is a Hematologist at the QEII Health Sciences Center. She is a Professor at Dalhousie University and teaches at the undergraduate and post graduate level. She has been Program Director for the Hematology Residency Program and Hematology Unit Head for undergraduate medicine. She is involved in research, being the local Principle Investigator for studies in CLL, ITP, TTP and hemostasis. She was president of the AHCDC, previously on the executive for the Canadian Hematology Society, and a member and examiner of the Royal College Hematology Subspecialty Nucleus Subcommittee.